Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma.

Saved in:
Bibliographic Details
Title: Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma.
Authors: Sidana S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. surbhi.sidana@stanford.edu., Hosoya H; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Jensen A; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA, USA., Liu L; City of Hope Cancer Center, Duarte, CA, USA., Goyal A; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Hovanky V; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Sahaf B; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Correlative Science Unit, Stanford University, Stanford, CA, USA., Bharadwaj S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Latchford T; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Arai S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Leahy S; City of Hope Cancer Center, Duarte, CA, USA., Mei M; City of Hope Cancer Center, Duarte, CA, USA., Budde LE; City of Hope Cancer Center, Duarte, CA, USA., Muffly LS; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Dahiya S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Htut M; City of Hope Cancer Center, Duarte, CA, USA., Miklos D; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Janakiram M; City of Hope Cancer Center, Duarte, CA, USA.
Source: Blood cancer journal [Blood Cancer J] 2023 Oct 13; Vol. 13 (1), pp. 158. Date of Electronic Publication: 2023 Oct 13.
Publication Type: Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37833271
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sidana+S%22">Sidana S</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. surbhi.sidana@stanford.edu.<br /><searchLink fieldCode="AU" term="%22Hosoya+H%22">Hosoya H</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Jensen+A%22">Jensen A</searchLink>; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+L%22">Liu L</searchLink>; City of Hope Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Goyal+A%22">Goyal A</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hovanky+V%22">Hovanky V</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sahaf+B%22">Sahaf B</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Correlative Science Unit, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bharadwaj+S%22">Bharadwaj S</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Latchford+T%22">Latchford T</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Arai+S%22">Arai S</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Leahy+S%22">Leahy S</searchLink>; City of Hope Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mei+M%22">Mei M</searchLink>; City of Hope Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Budde+LE%22">Budde LE</searchLink>; City of Hope Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Muffly+LS%22">Muffly LS</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Frank+MJ%22">Frank MJ</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Dahiya+S%22">Dahiya S</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Htut+M%22">Htut M</searchLink>; City of Hope Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Miklos+D%22">Miklos D</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Janakiram+M%22">Janakiram M</searchLink>; City of Hope Cancer Center, Duarte, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2023 Oct 13; Vol. 13 (1), pp. 158. <i>Date of Electronic Publication: </i>2023 Oct 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37833271
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-023-00929-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 158
    Titles:
      – TitleFull: Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sidana S
      – PersonEntity:
          Name:
            NameFull: Hosoya H
      – PersonEntity:
          Name:
            NameFull: Jensen A
      – PersonEntity:
          Name:
            NameFull: Liu L
      – PersonEntity:
          Name:
            NameFull: Goyal A
      – PersonEntity:
          Name:
            NameFull: Hovanky V
      – PersonEntity:
          Name:
            NameFull: Sahaf B
      – PersonEntity:
          Name:
            NameFull: Bharadwaj S
      – PersonEntity:
          Name:
            NameFull: Latchford T
      – PersonEntity:
          Name:
            NameFull: Arai S
      – PersonEntity:
          Name:
            NameFull: Leahy S
      – PersonEntity:
          Name:
            NameFull: Mei M
      – PersonEntity:
          Name:
            NameFull: Budde LE
      – PersonEntity:
          Name:
            NameFull: Muffly LS
      – PersonEntity:
          Name:
            NameFull: Frank MJ
      – PersonEntity:
          Name:
            NameFull: Dahiya S
      – PersonEntity:
          Name:
            NameFull: Htut M
      – PersonEntity:
          Name:
            NameFull: Miklos D
      – PersonEntity:
          Name:
            NameFull: Janakiram M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 10
              Text: 2023 Oct 13
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1